Health Care & Life Sciences » Pharmaceuticals | Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC | Mutual Funds

Mutual Funds that own Dechra Pharmaceuticals PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
American Funds Small Cap World Fund
3,260,018
3.19%
0
0.35%
06/30/2018
Standard Life Investment Co. ICVC - UK Smaller Companies Fund
2,502,963
2.45%
0
4.84%
08/31/2018
Government Pension Fund - Global (The)
2,449,718
2.39%
-56,635
0.01%
12/31/2017
Fidelity Select Health Care Portfolio
2,020,000
1.97%
0
1.08%
07/31/2018
Fidelity Series International Small Cap Fund
1,907,363
1.86%
0
2.31%
04/30/2018
Vanguard Total International Stock Index Fund
1,411,274
1.38%
21,560
0.02%
07/31/2018
Echiquier Agenor
1,170,000
1.13%
625,000
6%
03/29/2018
Marlborough Special Situations Fund
1,108,371
1.08%
-69,341
2.12%
03/29/2018
Rathbone Income Fund
1,025,000
1%
-75,000
2.29%
01/31/2018
Fidelity Advisor Health Care Fund
960,000
0.94%
0
1.13%
07/31/2018

About Dechra Pharmaceuticals

View Profile
Address
Cheshire Business Park
Northwich Cheshire CW9 7UA
United Kingdom
Employees -
Website http://dechra.com
Updated 07/08/2019
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe.